Bausch Health Companies (BHC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.30, -0.16% vs the prior close of $6.31.
- Volume 2.16M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BHC ends flat (-0.2%) to $6.30. Closed at $6.30, -0.16% vs the prior close of $6.31. Day range $6.20–$6.39, opened at $6.35.
BHC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BHC ends flat (-0.2%) to $6.30
- Closed at $6.30, -0.16% vs the prior close of $6.31. Day range $6.20–$6.39, opened at $6.35.
- Volume was 2.16M shares, 0.9x its 50-day average of 2.36M.
- Price is +2.2% vs its 50-day average ($6.16) and +10.0% vs its 200-day average ($5.73).
- 52-week range $4.33–$8.00; today's close sits at 54% of that range, 21.2% below the 52-week high.
Oct 15, 2026 — BHC jumps 7.1% to $6.31, a 1-month high
- Closed at $6.31, +7.13% vs the prior close of $5.89. Day range $5.95–$6.35, opened at $5.95.
- Volume was 2.31M shares, 1.0x its 50-day average of 2.40M.
- Price is +2.5% vs its 50-day average ($6.15) and +10.1% vs its 200-day average ($5.73).
- 52-week range $4.33–$8.00; today's close sits at 54% of that range, 21.1% below the 52-week high.
Oct 14, 2026 — BHC ends flat (+0.0%) to $5.89, 5 down days in a row
- Closed at $5.89, +0.00% vs the prior close of $5.89. Day range $5.85–$6.05, opened at $5.89.
- Volume was 1.75M shares, 0.6x its 50-day average of 2.71M.
- Price is -4.3% vs its 50-day average ($6.15) and +2.7% vs its 200-day average ($5.74).
- 52-week range $4.33–$8.00; today's close sits at 43% of that range, 26.4% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — BHC dips 0.7% to $5.89, 4 down days in a row
- Closed at $5.89, -0.67% vs the prior close of $5.93. Day range $5.73–$5.92, opened at $5.91.
- Volume was 1.56M shares, 0.5x its 50-day average of 2.87M — lighter than usual.
- Price is -4.5% vs its 50-day average ($6.16) and +2.6% vs its 200-day average ($5.74).
- 52-week range $4.33–$8.00; today's close sits at 43% of that range, 26.4% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — BHC dips 1.8% to $5.93, 3 down days in a row
- Closed at $5.93, -1.82% vs the prior close of $6.04. Day range $5.77–$6.35, opened at $6.27.
- Volume was 2.54M shares, 0.8x its 50-day average of 3.27M.
- Price is -4.2% vs its 50-day average ($6.19) and +3.1% vs its 200-day average ($5.75).
- 52-week range $4.33–$8.00; today's close sits at 44% of that range, 25.9% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — BHC ends flat (+0.0%) to $6.04
- Closed at $6.04, +0.00% vs the prior close of $6.04. Day range $6.02–$6.17, opened at $6.05.
- Volume was 1.03M shares, 0.3x its 50-day average of 3.63M — lighter than usual.
- Price is -2.7% vs its 50-day average ($6.21) and +4.9% vs its 200-day average ($5.76).
- 52-week range $4.33–$8.00; today's close sits at 47% of that range, 24.5% below the 52-week high.
Oct 8, 2026 — BHC dips 1.8% to $6.04
- Closed at $6.04, -1.79% vs the prior close of $6.15. Day range $6.02–$6.20, opened at $6.14.
- Volume was 1.27M shares, 0.3x its 50-day average of 3.67M — lighter than usual.
- Price is -2.7% vs its 50-day average ($6.21) and +4.8% vs its 200-day average ($5.76).
- 52-week range $4.33–$8.00; today's close sits at 47% of that range, 24.5% below the 52-week high.
Oct 7, 2026 — BHC rises 2.2% to $6.15, 4 up days in a row
- Closed at $6.15, +2.16% vs the prior close of $6.02. Day range $6.02–$6.33, opened at $6.04.
- Volume was 2.01M shares, 0.5x its 50-day average of 3.66M — lighter than usual.
- Price is -0.5% vs its 50-day average ($6.18) and +6.7% vs its 200-day average ($5.77).
- 52-week range $4.33–$8.00; today's close sits at 50% of that range, 23.1% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — BHC rises 2.2% to $6.02, 3 up days in a row
- Closed at $6.02, +2.21% vs the prior close of $5.89. Day range $5.83–$6.11, opened at $5.94.
- Volume was 3.05M shares, 0.8x its 50-day average of 3.63M.
- Price is -2.1% vs its 50-day average ($6.15) and +4.3% vs its 200-day average ($5.77).
- 52-week range $4.33–$8.00; today's close sits at 46% of that range, 24.8% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — BHC rises 1.6% to $5.89
- Closed at $5.89, +1.55% vs the prior close of $5.80. Day range $5.71–$5.96, opened at $5.73.
- Volume was 1.47M shares, 0.4x its 50-day average of 3.63M — lighter than usual.
- Price is -3.7% vs its 50-day average ($6.12) and +2.0% vs its 200-day average ($5.77).
- 52-week range $4.33–$8.00; today's close sits at 43% of that range, 26.4% below the 52-week high.
Oct 2, 2026 — BHC rises 1.2% to $5.80
- Closed at $5.80, +1.22% vs the prior close of $5.73. Day range $5.61–$5.87, opened at $5.73.
- Volume was 3.28M shares, 0.9x its 50-day average of 3.59M.
- Price is -4.7% vs its 50-day average ($6.09) and +0.4% vs its 200-day average ($5.78).
- 52-week range $4.33–$8.00; today's close sits at 40% of that range, 27.5% below the 52-week high.
BHC latest news & SEC filings
Every SEC filing by or about BHC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Paulson John received an award of 10,720 shares at $5.83 (≈$62.50K) on Sep 30, 2026; now holds 440,962
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Leung Sandra received an award of 5,789 shares at $5.83 (≈$33.75K) on Sep 30, 2026; now holds 102,859
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wechsler Amy B received an award of 1,179 shares at $5.83 (≈$6.87K) on Sep 30, 2026; now holds 316,158
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lenar Aimee J. sold 36,827 shares at $7.03 (≈$258.89K) on Aug 19, 2026
- Lenar Aimee J. sold 36,827 shares at $7.03 (≈$258.89K) on Aug 19, 2026
- Lenar Aimee J. sold 36,827 shares at $7.03 (≈$258.89K) on Aug 19, 2026
- Lenar Aimee J. sold 36,827 shares at $7.03 (≈$258.89K) on Aug 19, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 19, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 30, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $2.85B (prior year $2.53B) (+12.7% vs Jun 30, 2025)
- Net income: $258.00M (prior year $148.00M) (+74.3% vs Jun 30, 2025)
- Diluted EPS: $0.68 (prior year $0.40) (+70.0% vs Jun 30, 2025)
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade BHC
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 29, 2026, Feb 18, 2026, Jan 13, 2026. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.49% (largest 7.1%).
- Liquidity: about 1.83M shares (≈$11.55M) trade per day on average.
- 52-week position: $6.30 vs a range of $4.33–$8.00 (54% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 20 sales; latest: Aimee J. Lenar sold 36,827 shares on Aug 19, 2026.
- Latest filings: 10-Q Jul 30, 2026; 8-K Jul 29, 2026; 8-K Jul 1, 2026.
- Share count: 373.99M shares outstanding (Jul 24, 2026), +1.1% vs a year earlier.
- Listing: NYSE · industry: Pharmaceutical Preparations.
BHC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.35 | 6.39 | 6.20 | 6.30 | 2.16M |
| Oct 15, 2026 | 5.95 | 6.35 | 5.95 | 6.31 | 2.31M |
| Oct 14, 2026 | 5.89 | 6.05 | 5.85 | 5.89 | 1.75M |
| Oct 13, 2026 | 5.91 | 5.92 | 5.73 | 5.89 | 1.56M |
| Oct 12, 2026 | 6.27 | 6.35 | 5.77 | 5.93 | 2.54M |
| Oct 9, 2026 | 6.05 | 6.17 | 6.02 | 6.04 | 1.03M |
| Oct 8, 2026 | 6.14 | 6.20 | 6.02 | 6.04 | 1.27M |
| Oct 7, 2026 | 6.04 | 6.33 | 6.02 | 6.15 | 2.01M |
| Oct 6, 2026 | 5.94 | 6.11 | 5.83 | 6.02 | 3.05M |
| Oct 5, 2026 | 5.73 | 5.96 | 5.71 | 5.89 | 1.47M |
| Oct 2, 2026 | 5.73 | 5.87 | 5.61 | 5.80 | 3.28M |
| Oct 1, 2026 | 5.84 | 5.86 | 5.65 | 5.73 | 1.45M |
| Sep 30, 2026 | 5.83 | 5.93 | 5.72 | 5.83 | 1.46M |
| Sep 29, 2026 | 5.74 | 5.80 | 5.69 | 5.80 | 1.28M |
| Sep 28, 2026 | 5.66 | 5.85 | 5.60 | 5.77 | 1.51M |
| Sep 25, 2026 | 5.66 | 5.83 | 5.63 | 5.69 | 1.25M |
| Sep 24, 2026 | 5.67 | 5.78 | 5.54 | 5.65 | 2.02M |
| Sep 23, 2026 | 5.82 | 5.93 | 5.67 | 5.71 | 1.82M |
| Sep 22, 2026 | 5.76 | 5.82 | 5.62 | 5.81 | 1.91M |
| Sep 21, 2026 | 5.67 | 5.74 | 5.56 | 5.64 | 1.54M |
About Bausch Health Companies
Bausch Health Companies (BHC) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in QUEBEC, Quebec, Canada. State of incorporation: NJ. Fiscal year ends December 31. SEC CIK 885590.
BHC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Thomas Appio | Chief Executive Officer | Mar 3, 2026 |
| Michael Goettler | Director | May 26, 2026 |
| Christian A Garcia | Director | May 26, 2026 |
| Sarah B Kavanagh | Director | May 26, 2026 |
| Sandra Leung | Director | Jul 2, 2026 |
| Frank D. Lee | Director | May 26, 2026 |
| Robert N Power | Director | May 26, 2026 |
| John Paulson | Director | Jul 2, 2026 |
| Eiry Roberts | Director | May 26, 2026 |
| Amy B Wechsler | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Thomas Appio | Chief Executive Officer | Mar 3, 2026 |
| Seana Carson | EVP, General Counsel | Mar 3, 2026 |
| Jean-Jacques Charhon | EVP, CFO | Mar 3, 2026 |
| Steven Hyosig Lee | SVP, Controller & CAO | Jul 15, 2026 |
| Aimee J. Lenar | President, US Pharma | Aug 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | Aimee J. Lenar | Sale | 36,827 | $7.03 |
| Aug 19, 2026 | Aimee J. Lenar | Sale | 36,827 | $7.03 |
| Aug 19, 2026 | Aimee J. Lenar | Sale | 36,827 | $7.03 |
| Aug 19, 2026 | Aimee J. Lenar | Sale | 36,827 | $7.03 |
| May 19, 2026 | Frank D. Lee | Sale | 24,456 | $5.43 |
| May 19, 2026 | Frank D. Lee | Sale | 24,456 | $5.43 |
| May 19, 2026 | Frank D. Lee | Sale | 24,456 | $5.43 |
| May 19, 2026 | Frank D. Lee | Sale | 24,456 | $5.43 |
| Mar 3, 2026 | Seana Carson | Sale | 4,420 | $5.77 |
| Mar 3, 2026 | Seana Carson | Sale | 4,420 | $5.77 |
| Mar 3, 2026 | Seana Carson | Sale | 4,420 | $5.77 |
| Mar 3, 2026 | Seana Carson | Sale | 4,420 | $5.77 |
| Mar 2, 2026 | Seana Carson | Sale | 6,856 | $5.78 |
| Mar 2, 2026 | Seana Carson | Sale | 6,856 | $5.78 |
| Mar 2, 2026 | Seana Carson | Sale | 6,856 | $5.78 |
BHC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $10.27B | $157.00M | 0.42 | $1.40B |
| Dec 31, 2024 | $9.62B | $-46.00M | -0.13 | $1.60B |
| Dec 31, 2023 | $8.76B | $-592.00M | -1.62 | $1.03B |
| Dec 31, 2022 | $8.12B | $-225.00M | -0.62 | $-728.00M |
| Dec 31, 2021 | $8.43B | $-948.00M | -2.64 | $1.43B |
Latest balance sheet: total assets $24.79B, total liabilities $25.60B, cash $1.82B (as of Jun 30, 2026).
BHC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $4.68 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $5.59 |
| Feb 18, 2026 | 8-K Item 2.02 (results) | $6.19 |
| Jan 13, 2026 | 8-K Item 2.02 (results) | $7.50 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $5.90 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $6.39 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $5.30 |
| Feb 19, 2025 | 8-K Item 2.02 (results) | $6.51 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $8.17 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 22, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BHC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.